MENU
+Compare
IMMP
Stock ticker: NASDAQ
AS OF
Apr 25 closing price
Price
$1.63
Change
-$0.05 (-2.98%)
Capitalization
231.59M

IMMP Immutep Limited Forecast, Technical & Fundamental Analysis

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases... Show more

Industry: #Biotechnology
IMMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for IMMP with price predictions
Apr 25, 2025

IMMP's RSI Indicator ascending out of oversold territory

The RSI Indicator for IMMP moved out of oversold territory on April 11, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 25 similar instances when the indicator left oversold territory. In of the 25 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 21, 2025. You may want to consider a long position or call options on IMMP as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IMMP just turned positive on April 21, 2025. Looking at past instances where IMMP's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IMMP advanced for three days, in of 253 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMMP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IMMP broke above its upper Bollinger Band on April 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for IMMP entered a downward trend on March 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.162) is normal, around the industry mean (14.255). P/E Ratio (0.000) is within average values for comparable stocks, (63.920). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.829). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (254.270).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMMP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. IMMP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
IMMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

IMMP is expected to report earnings to rise 563.50% to -13 cents per share on August 29

Immutep Limited IMMP Stock Earnings Reports
Q2'24
Est.
$-0.13
Q4'24
Beat
by $0.12
Q4'23
Missed
by $0.05
Q2'23
Est.
$-0.15
Q4'22
Beat
by $0.01
The last earnings report on February 26 showed earnings per share of -1 cents, beating the estimate of -14 cents. With 60.69K shares outstanding, the current market capitalization sits at 231.59M.
A.I. Advisor
published General Information

General Information

a developer of anti-cancer therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
264 George Street
Phone
+61 283157003
Employees
24
Web
https://www.immutep.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGSIX65.350.96
+1.49%
BlackRock Technology Opportunities Instl
ARALX12.950.10
+0.78%
Aristotle Core Eq A
EKBYX12.330.08
+0.65%
Allspring Diversified Cap Bldr Inst
VSFSX21.82-0.05
-0.23%
Federated Hermes Clover Small Value R6
VIKSX10.41-0.16
-1.51%
Virtus KAR Small-Mid Cap Growth I

IMMP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IMMP has been loosely correlated with PRRUF. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IMMP jumps, then PRRUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMP
1D Price
Change %
IMMP100%
-2.98%
PRRUF - IMMP
43%
Loosely correlated
N/A
CALC - IMMP
39%
Loosely correlated
-1.64%
XFOR - IMMP
37%
Loosely correlated
+1.50%
ARCT - IMMP
31%
Poorly correlated
+0.16%
AXON - IMMP
31%
Poorly correlated
+2.22%
More